Nyse Tmbr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (

Timber Pharmaceuticals (NYSE:TMBR – Get Free Report) and Relmada Therapeutics (NASDAQ:RLMD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of […]

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a...

Timber Pharmaceuticals, Inc. (NYSE:TMBR – Get Rating) shares were up 1.4% during mid-day trading on Wednesday . The stock traded as high as $1.42 and last traded at $1.40. Approximately 23,453 shares changed hands during trading, a decline of 97% from the average daily volume of 811,045 shares. The stock had previously closed at $1.38. […]

Timber Pharmaceuticals (NYSE:TMBR – Get Rating) and Seres Therapeutics (NASDAQ:MCRB – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk. Profitability This table compares Timber Pharmaceuticals and Seres Therapeutics’ […]